Decision

Amgen Canada Inc. v. Apotex Inc., 2016 FCA 121 (Filgrastim*)

Justice Stratas - 2016-04-20

Read full decision. Automatically generated summary:

Amgen brought a motion to dismiss the appeal on the basis of mootness. On the motion, Apotex brought it own motion to introduce evidence in reply. The court considered the rules and jurisprudence for reply evidence and in this case granted Apotex's motion to file reply evidence and for Amgen to cross-examine on that evidence.

Decision relates to:

 

Canadian Intellectual Property